Refoxy Pharmaceuticals raised €9.1M in a Seed extension round led by Boehringer Ingelheim Venture Fund to advance their research on therapeutics for age-related diseases.
Amount Raised
€9.1 Million
Round Type
Seed
Investors
Description
Biotech Refoxy Pharmaceuticals has successfully raised €9.1 million in Seed-extension financing. The funding will support their development of novel therapeutic medicines, particularly targeting idiopathic pulmonary fibrosis (IPF).
Who to call at Refoxy Pharmaceuticals, and when
A new round usually means Refoxy Pharmaceuticals is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Refoxy Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Refoxy Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Refoxy Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Refoxy Pharmaceuticals raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Refoxy Pharmaceuticals raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.